← Back to headlines
Biotech Fund Invests $12 Million in Immunome, Stock Surges
A biotech-focused fund has added $12 million to its investment in Immunome, leading to a significant 120% surge in the company's stock.
22 Feb, 18:23 — 22 Feb, 18:23
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
EU Rejects US Tariff Increase Following Supreme Court Decision
1m ago
DAE Nears Deal to Acquire Controlling Stake in Macquarie AirFinance
1m ago
The uncertainties facing businesses and consumers after Trump's tariff changes
1m ago
UK Risks Being the Biggest Loser From Trump’s Tariff Changes - Bloomberg
1m ago